Jonathan W. Ayers - May 11, 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan W. Ayers
Stock symbol
IDXX
Transactions as of
May 11, 2022
Transactions value $
$0
Form type
4
Date filed
5/13/2022, 05:36 PM
Previous filing
Feb 22, 2022
Next filing
Sep 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +224 +0.04% $0.00 630K May 11, 2022 Direct
holding IDXX Common Stock 10K May 11, 2022 by Ayers Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award +945 945 May 11, 2022 Common Stock 945 $333.90 Direct F1, F4
transaction IDXX Restricted Stock Unit Award +344 +153.57% 568 May 11, 2022 Common Stock 344 Direct F2, F4
transaction IDXX Restricted Stock Unit Options Exercise -224 -39.44% 344 May 11, 2022 Common Stock 224 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier.
F2 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier.
F3 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in in one installment on the one year anniversary of the date of grant or on the date of the 2022 annual meeting of shareholders, whichever event was earlier.
F4 Not applicable.